View Future GrowthEagle Veterinary TechnologyLtd 過去の業績過去 基準チェック /56Eagle Veterinary TechnologyLtdは、平均年間0.5%の収益成長を遂げていますが、 Pharmaceuticals業界の収益は、年間 成長しています。収益は、平均年間12% 0.8%収益成長率で 成長しています。 Eagle Veterinary TechnologyLtdの自己資本利益率は8.3%であり、純利益率は9.9%です。主要情報0.45%収益成長率0.45%EPS成長率Pharmaceuticals 業界の成長11.32%収益成長率0.83%株主資本利益率8.28%ネット・マージン9.94%前回の決算情報31 Mar 2026最近の業績更新Reported Earnings • Nov 20Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: ₩10.5b (up 5.9% from 3Q 2024). Net income: ₩422.5m (up 128% from 3Q 2024). Profit margin: 4.0% (up from 1.9% in 3Q 2024). The increase in margin was driven by higher revenue.すべての更新を表示Recent updatesお知らせ • Feb 20Eagle Veterinary Technology Co.,Ltd, Annual General Meeting, Mar 25, 2026Eagle Veterinary Technology Co.,Ltd, Annual General Meeting, Mar 25, 2026, at 11:30 Tokyo Standard Time. Location: conference room, 235-34, chusa-ro, sinam-myeon, yesan-gun, chungcheongnam-do, South Koreaお知らせ • Dec 25Eagle Veterinary Technology Co.,Ltd announced that it has received KRW 1.77621224 billion in fundingOn December 23, 2025. Eagle Veterinary Technology Co.,Ltd announces that it has closed the transaction.Upcoming Dividend • Dec 22Upcoming dividend of ₩60.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 09 April 2026. Trailing yield: 1.3%. Lower than top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (0.8%).Reported Earnings • Nov 20Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: ₩10.5b (up 5.9% from 3Q 2024). Net income: ₩422.5m (up 128% from 3Q 2024). Profit margin: 4.0% (up from 1.9% in 3Q 2024). The increase in margin was driven by higher revenue.Declared Dividend • Nov 08Dividend of ₩60.00 announcedDividend of ₩60.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 9th April 2026 Dividend yield will be 1.5%, which is higher than the industry average of 1.1%. Sustainability & Growth The dividend has increased by an average of 14% per year over the past 3 years and payments have been stable during that time.お知らせ • Nov 07Eagle Veterinary Technology Co.,Ltd announces Annual dividend, payable on April 09, 2026Eagle Veterinary Technology Co.,Ltd announced Annual dividend of KRW 60.0000 per share payable on April 09, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.お知らせ • Feb 13Eagle Veterinary Technology Co.,Ltd, Annual General Meeting, Mar 19, 2025Eagle Veterinary Technology Co.,Ltd, Annual General Meeting, Mar 19, 2025, at 11:30 Tokyo Standard Time. Location: conference room, 235-34, chusa-ro, sinam-myeon, yesan-gun, chungcheongnam-do, South KoreaUpcoming Dividend • Dec 20Upcoming dividend of ₩40.00 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 17 April 2025. Trailing yield: 0.8%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (1.1%).分析記事 • Aug 12Here's Why Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Can Manage Its Debt ResponsiblyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Upcoming Dividend • Dec 20Upcoming dividend of ₩40.00 per share at 0.7% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 17 April 2024. Trailing yield: 0.7%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.1%).New Risk • Oct 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.5% average weekly change). Market cap is less than US$100m (₩86.6b market cap, or US$64.0m).Valuation Update With 7 Day Price Move • Oct 23Investor sentiment improves as stock rises 35%After last week's 35% share price gain to ₩6,850, the stock trades at a trailing P/E ratio of 35.6x. Average trailing P/E is 15x in the Pharmaceuticals industry in South Korea. Total loss to shareholders of 19% over the past three years.Valuation Update With 7 Day Price Move • May 12Investor sentiment improves as stock rises 35%After last week's 35% share price gain to ₩7,070, the stock trades at a trailing P/E ratio of 33.8x. Average trailing P/E is 21x in the Pharmaceuticals industry in South Korea. Negligible returns to shareholders over past three years.Upcoming Dividend • Dec 21Inaugural dividend of ₩50.00 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 18 April 2023. This is the first dividend for Eagle Veterinary TechnologyLtd since going public. The average dividend yield among industry peers is 1.0%.Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩5,400, the stock trades at a trailing P/E ratio of 21.6x. Average trailing P/E is 19x in the Pharmaceuticals industry in South Korea. Total loss to shareholders of 25% over the past three years.Upcoming Dividend • Dec 22Inaugural dividend of ₩40.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 14 April 2022. The company is not currently making a profit but it is cash flow positive. This is the first dividend for Eagle Veterinary TechnologyLtd since going public. The average dividend yield among industry peers is 0.8%.分析記事 • Apr 11Do Eagle Veterinary TechnologyLtd's (KOSDAQ:044960) Earnings Warrant Your Attention?Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...分析記事 • Mar 21Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Seems To Use Debt Rather SparinglyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Is New 90 Day High Low • Feb 23New 90-day low: ₩8,060The company is down 11% from its price of ₩9,010 on 25 November 2020. The South Korean market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is down 4.0% over the same period.分析記事 • Feb 21Is Eagle Veterinary Technology Co.,Ltd's (KOSDAQ:044960) Recent Price Movement Underpinned By Its Weak Fundamentals?It is hard to get excited after looking at Eagle Veterinary TechnologyLtd's (KOSDAQ:044960) recent performance, when...Is New 90 Day High Low • Jan 29New 90-day low: ₩8,220The company is down 7.0% from its price of ₩8,800 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 14% over the same period.分析記事 • Jan 10Investors Who Bought Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Shares Three Years Ago Are Now Up 84%It might be of some concern to shareholders to see the Eagle Veterinary Technology Co.,Ltd ( KOSDAQ:044960 ) share...Valuation Update With 7 Day Price Move • Dec 25Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩9,370, the stock is trading at a trailing P/E ratio of 60.9x, down from the previous P/E ratio of 71.9x. This compares to an average P/E of 30x in the Pharmaceuticals industry in South Korea. Total returns to shareholders over the past three years are 84%.分析記事 • Dec 20Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Has A Rock Solid Balance SheetDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Valuation Update With 7 Day Price Move • Dec 02Market bids up stock over the past weekAfter last week's 21% share price gain to ₩10,900, the stock is trading at a trailing P/E ratio of 70.9x, up from the previous P/E ratio of 58.6x. This compares to an average P/E of 30x in the Pharmaceuticals industry in South Korea. Total returns to shareholders over the past three years are 103%.Is New 90 Day High Low • Dec 01New 90-day high: ₩10,200The company is up 9.0% from its price of ₩9,390 on 02 September 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Pharmaceuticals industry, which is up 3.0% over the same period.分析記事 • Nov 23Eagle Veterinary Technology Co.,Ltd's (KOSDAQ:044960) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?Eagle Veterinary TechnologyLtd's (KOSDAQ:044960) stock is up by a considerable 11% over the past three months...Is New 90 Day High Low • Oct 12New 90-day high: ₩9,730The company is up 13% from its price of ₩8,620 on 14 July 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Pharmaceuticals industry, which is also up 13% over the same period.収支内訳Eagle Veterinary TechnologyLtd の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史KOSDAQ:A044960 収益、費用、利益 ( )KRW Millions日付収益収益G+A経費研究開発費31 Mar 2643,6104,3349,33951531 Dec 2543,3233,9469,11754330 Sep 2542,5103,6869,14255530 Jun 2541,9273,4498,56040731 Mar 2541,8573,3149,45337331 Dec 2441,7173,7059,29635530 Sep 2441,5692,6659,86633330 Jun 2442,0912,97010,49937131 Mar 2442,1922,89610,58031331 Dec 2342,7942,97610,29229530 Sep 2343,1452,76610,01724030 Jun 2343,1262,43210,03817931 Mar 2343,8772,76210,15114431 Dec 2243,5402,64310,58112730 Sep 2244,0222,56212,00113030 Jun 2242,9183,15911,20518931 Mar 2241,4443,81410,13715931 Dec 2140,4373,6389,95914030 Sep 2139,5524,6177,69017030 Jun 2140,4714,3907,71411431 Mar 2140,7102,9668,16013531 Dec 2040,3572,4598,02412930 Sep 2039,0861,8878,30016230 Jun 2037,2611,6188,00116931 Mar 2035,7741,4897,28416731 Dec 1934,4231,2326,91216430 Sep 1932,9311,1326,82013730 Jun 1931,5187496,72513731 Mar 1930,3049246,79716331 Dec 1830,2621,0426,82519730 Sep 1831,0278927,01120330 Jun 1831,9011,2726,85921531 Mar 1833,4801,5446,98625631 Dec 1734,1561,5557,08024830 Sep 1734,3693,3477,09129830 Jun 1733,4253,0397,03925931 Mar 1731,1462,5816,85821731 Dec 1628,8462,2346,83919030 Sep 1626,6254836,50111530 Jun 1626,3267456,39412431 Mar 1625,7118526,6029531 Dec 1525,1051,0346,56812330 Sep 1524,2531,1396,414126質の高い収益: A044960は 高品質の収益 を持っています。利益率の向上: A044960の現在の純利益率 (9.9%)は、昨年(7.9%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: A044960の収益は過去 5 年間で年間0.5%増加しました。成長の加速: A044960の過去 1 年間の収益成長率 ( 30.8% ) は、5 年間の平均 ( 年間0.5%を上回っています。収益対業界: A044960の過去 1 年間の収益成長率 ( 30.8% ) はPharmaceuticals業界28.8%を上回りました。株主資本利益率高いROE: A044960の 自己資本利益率 ( 8.3% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/06 07:57終値2026/07/06 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Eagle Veterinary Technology Co.,Ltd 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • Nov 20Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: ₩10.5b (up 5.9% from 3Q 2024). Net income: ₩422.5m (up 128% from 3Q 2024). Profit margin: 4.0% (up from 1.9% in 3Q 2024). The increase in margin was driven by higher revenue.
お知らせ • Feb 20Eagle Veterinary Technology Co.,Ltd, Annual General Meeting, Mar 25, 2026Eagle Veterinary Technology Co.,Ltd, Annual General Meeting, Mar 25, 2026, at 11:30 Tokyo Standard Time. Location: conference room, 235-34, chusa-ro, sinam-myeon, yesan-gun, chungcheongnam-do, South Korea
お知らせ • Dec 25Eagle Veterinary Technology Co.,Ltd announced that it has received KRW 1.77621224 billion in fundingOn December 23, 2025. Eagle Veterinary Technology Co.,Ltd announces that it has closed the transaction.
Upcoming Dividend • Dec 22Upcoming dividend of ₩60.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 09 April 2026. Trailing yield: 1.3%. Lower than top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (0.8%).
Reported Earnings • Nov 20Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: ₩10.5b (up 5.9% from 3Q 2024). Net income: ₩422.5m (up 128% from 3Q 2024). Profit margin: 4.0% (up from 1.9% in 3Q 2024). The increase in margin was driven by higher revenue.
Declared Dividend • Nov 08Dividend of ₩60.00 announcedDividend of ₩60.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 9th April 2026 Dividend yield will be 1.5%, which is higher than the industry average of 1.1%. Sustainability & Growth The dividend has increased by an average of 14% per year over the past 3 years and payments have been stable during that time.
お知らせ • Nov 07Eagle Veterinary Technology Co.,Ltd announces Annual dividend, payable on April 09, 2026Eagle Veterinary Technology Co.,Ltd announced Annual dividend of KRW 60.0000 per share payable on April 09, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.
お知らせ • Feb 13Eagle Veterinary Technology Co.,Ltd, Annual General Meeting, Mar 19, 2025Eagle Veterinary Technology Co.,Ltd, Annual General Meeting, Mar 19, 2025, at 11:30 Tokyo Standard Time. Location: conference room, 235-34, chusa-ro, sinam-myeon, yesan-gun, chungcheongnam-do, South Korea
Upcoming Dividend • Dec 20Upcoming dividend of ₩40.00 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 17 April 2025. Trailing yield: 0.8%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (1.1%).
分析記事 • Aug 12Here's Why Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Can Manage Its Debt ResponsiblyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Upcoming Dividend • Dec 20Upcoming dividend of ₩40.00 per share at 0.7% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 17 April 2024. Trailing yield: 0.7%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.1%).
New Risk • Oct 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.5% average weekly change). Market cap is less than US$100m (₩86.6b market cap, or US$64.0m).
Valuation Update With 7 Day Price Move • Oct 23Investor sentiment improves as stock rises 35%After last week's 35% share price gain to ₩6,850, the stock trades at a trailing P/E ratio of 35.6x. Average trailing P/E is 15x in the Pharmaceuticals industry in South Korea. Total loss to shareholders of 19% over the past three years.
Valuation Update With 7 Day Price Move • May 12Investor sentiment improves as stock rises 35%After last week's 35% share price gain to ₩7,070, the stock trades at a trailing P/E ratio of 33.8x. Average trailing P/E is 21x in the Pharmaceuticals industry in South Korea. Negligible returns to shareholders over past three years.
Upcoming Dividend • Dec 21Inaugural dividend of ₩50.00 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 18 April 2023. This is the first dividend for Eagle Veterinary TechnologyLtd since going public. The average dividend yield among industry peers is 1.0%.
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩5,400, the stock trades at a trailing P/E ratio of 21.6x. Average trailing P/E is 19x in the Pharmaceuticals industry in South Korea. Total loss to shareholders of 25% over the past three years.
Upcoming Dividend • Dec 22Inaugural dividend of ₩40.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 14 April 2022. The company is not currently making a profit but it is cash flow positive. This is the first dividend for Eagle Veterinary TechnologyLtd since going public. The average dividend yield among industry peers is 0.8%.
分析記事 • Apr 11Do Eagle Veterinary TechnologyLtd's (KOSDAQ:044960) Earnings Warrant Your Attention?Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
分析記事 • Mar 21Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Seems To Use Debt Rather SparinglyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Is New 90 Day High Low • Feb 23New 90-day low: ₩8,060The company is down 11% from its price of ₩9,010 on 25 November 2020. The South Korean market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is down 4.0% over the same period.
分析記事 • Feb 21Is Eagle Veterinary Technology Co.,Ltd's (KOSDAQ:044960) Recent Price Movement Underpinned By Its Weak Fundamentals?It is hard to get excited after looking at Eagle Veterinary TechnologyLtd's (KOSDAQ:044960) recent performance, when...
Is New 90 Day High Low • Jan 29New 90-day low: ₩8,220The company is down 7.0% from its price of ₩8,800 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 14% over the same period.
分析記事 • Jan 10Investors Who Bought Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Shares Three Years Ago Are Now Up 84%It might be of some concern to shareholders to see the Eagle Veterinary Technology Co.,Ltd ( KOSDAQ:044960 ) share...
Valuation Update With 7 Day Price Move • Dec 25Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩9,370, the stock is trading at a trailing P/E ratio of 60.9x, down from the previous P/E ratio of 71.9x. This compares to an average P/E of 30x in the Pharmaceuticals industry in South Korea. Total returns to shareholders over the past three years are 84%.
分析記事 • Dec 20Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Has A Rock Solid Balance SheetDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Valuation Update With 7 Day Price Move • Dec 02Market bids up stock over the past weekAfter last week's 21% share price gain to ₩10,900, the stock is trading at a trailing P/E ratio of 70.9x, up from the previous P/E ratio of 58.6x. This compares to an average P/E of 30x in the Pharmaceuticals industry in South Korea. Total returns to shareholders over the past three years are 103%.
Is New 90 Day High Low • Dec 01New 90-day high: ₩10,200The company is up 9.0% from its price of ₩9,390 on 02 September 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Pharmaceuticals industry, which is up 3.0% over the same period.
分析記事 • Nov 23Eagle Veterinary Technology Co.,Ltd's (KOSDAQ:044960) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?Eagle Veterinary TechnologyLtd's (KOSDAQ:044960) stock is up by a considerable 11% over the past three months...
Is New 90 Day High Low • Oct 12New 90-day high: ₩9,730The company is up 13% from its price of ₩8,620 on 14 July 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Pharmaceuticals industry, which is also up 13% over the same period.